» Articles » PMID: 25624489

Pan-viral-microRNA Screening Identifies Interferon Inhibition As a Common Function of Diverse Viruses

Overview
Specialty Science
Date 2015 Jan 28
PMID 25624489
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Diverse viruses encode regulatory RNAs called microRNAs (miRNAs). Despite much progress, the functions of the majority of viral miRNAs remain unknown. Most previous studies have used biochemical methods to uncover targets of viral miRNAs, but it is unclear what fraction of these targets is functionally important. Here, we apply an alternative strategy based on the premise that assorted viral miRNAs will share functionality. Screening a library of >70 human viral miRNAs showed that three unrelated miRNAs from distantly related herpesviruses significantly inhibited IFN signaling. Strikingly, each of these miRNAs directly reduced expression of the cyclic AMP-responsive element-binding protein (CBP), which as part of the p300-CBP complex, mediates IFN signaling. We show that both 5' and 3' derivatives from Epstein-Barr virus (EBV) encoded miR-BART-18 precursor miRNA (pre-miRNA) and the orthologous pre-miRNA from Rhesus lymphocryptovirus contribute to reducing IFN signaling. Thus, through both convergent and divergent evolutionary mechanisms, varied herpesviral miRNAs share the ability to decrease IFN signaling. Restoring miR-BART-18 to cells infected with an EBV miRNA mutant conveyed a cellular growth advantage upon IFN treatment, and relevant miRNAs from other herpesviruses were able to complement this activity. Blocking miR-BART-18 function in an EBV(+) tumor cell line renders cells more susceptible to IFN-mediated effects. These findings provide a mechanism that can at least partially explain the resistance of some EBV-associated tumors to IFN therapy. Our work suggests that similar pan-viral-miRNA functional-based screening strategies are warranted for determining relevant activities of other viral miRNAs.

Citing Articles

How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses.

Arleevskaya M, Kravtsova O, Lemerle J, Renaudineau Y, Tsibulkin A Front Microbiol. 2016; 7:1296.

PMID: 27582741 PMC: 4987382. DOI: 10.3389/fmicb.2016.01296.


MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations.

Louten J, Beach M, Palermino K, Weeks M, Holenstein G Biomark Insights. 2016; 10(Suppl 4):25-52.

PMID: 26819546 PMC: 4718089. DOI: 10.4137/BMI.S29512.


lncRNA-mediated regulation of the interferon response.

Valadkhan S, Gunawardane L Virus Res. 2015; 212:127-36.

PMID: 26474526 PMC: 4744491. DOI: 10.1016/j.virusres.2015.09.023.


The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer.

Moens U, Rasheed K, Abdulsalam I, Sveinbjornsson B Viruses. 2015; 7(4):1871-901.

PMID: 25866902 PMC: 4411681. DOI: 10.3390/v7041871.

References
1.
Ruf I, Rhyne P, Yang C, Cleveland J, Sample J . Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol. 2000; 74(21):10223-8. PMC: 102063. DOI: 10.1128/jvi.74.21.10223-10228.2000. View

2.
Straathof K, Bollard C, Rooney C, Heslop H . Immunotherapy for Epstein-Barr virus-associated cancers in children. Oncologist. 2003; 8(1):83-98. DOI: 10.1634/theoncologist.8-1-83. View

3.
Thompson M, Kurzrock R . Epstein-Barr virus and cancer. Clin Cancer Res. 2004; 10(3):803-21. DOI: 10.1158/1078-0432.ccr-0670-3. View

4.
Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser F . Identification of microRNAs of the herpesvirus family. Nat Methods. 2005; 2(4):269-76. DOI: 10.1038/nmeth746. View

5.
Takada K, Horinouchi K, Ono Y, Aya T, OSATO T, Takahashi M . An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes. 1991; 5(2):147-56. DOI: 10.1007/BF00571929. View